Develops diagnostic tests for dry eye disease.
Jun 2024Revenue $92.9K/yrExpenses $2.41M/yr
No trend
Figures by year
When will Axim Biotechnologies be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2024, revenue was $92.9K and expenses $2.41M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2023 | $39.5K | $2.79M | −$2.75M |
| Dec 2022 | $8.88K | $4.66M | −$4.65M |
| Dec 2021 | $60.5K | $14.0M | −$14.0M |
| Dec 2020 | $0.00 | $4.95M | −$4.95M |
| Dec 2019 | $799K | $3.91M | −$3.11M |
| Dec 2018 | $196K | $5.23M | −$5.04M |
| Dec 2017 | $47.6K | $3.20M | −$3.15M |
| Dec 2016 | $47.1K | $3.81M | −$3.76M |
| Dec 2015 | $49.1K | $10.1M | −$10.0M |
| Dec 2014 | $0.00 | $506K | −$506K |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.